| 000 -LEADER |
|---|
| fixed length control field |
01041nam a2200301 a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
BD-DhSUL |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20160314020334.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
160314s2003 nyua b 001 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0824708385 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
BD-DhSUL |
| Transcribing agency |
BD-DhSUL |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.1 |
| Edition number |
22 |
| Item number |
PHA |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Pharmaceutical process validation / |
| Statement of responsibility, etc. |
edited by Robert A. Nash, Alfred H. Wachter. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
International 3rd ed., rev. and expanded. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
New York : |
| Name of publisher, distributor, etc. |
Marcel Dekker, |
| Date of publication, distribution, etc. |
c2003. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xxxvi, 860 p. : |
| Other physical details |
ill. ; |
| Dimensions |
24 cm. |
| 365 ## - TRADE PRICE |
|---|
| Price type code |
BDT. |
| Price amount |
1200.00 |
| 490 1# - SERIES STATEMENT |
|---|
| Series statement |
Drugs and the pharmaceutical sciences ; |
| Volume/sequential designation |
129 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 526 ## - STUDY PROGRAM INFORMATION NOTE |
|---|
| Department/Program Name |
BPH |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmaceutical industry |
| General subdivision |
Quality control. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drugs |
| General subdivision |
Standards |
| Geographic subdivision |
United States. |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug Evaluation |
| General subdivision |
standards |
| Geographic subdivision |
United States. |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug Industry |
| General subdivision |
standards |
| Geographic subdivision |
United States. |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Quality Control. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Berry, Ira R., |
| Dates associated with a name |
1942- |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Nash, Robert A., |
| Dates associated with a name |
1930- |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Koha item type |
Siddeswari Campus-Book |